BPC-157 (500mcg) x 30 Tablets

Gastrointestinal Support:

Animal models show BPC‑157 Tablets provide anti-ulcer and mucosal protective effects, preserving stomach lining and maintaining tissue architecture . 

Tissue Healing & Angiogenesis:

Research in rodents demonstrates enhanced healing in tendons, ligaments, and skin wounds, often linked to increased angiogenesis and collagen formation [4][3]. 

Systemic Protective Activity:

Studies indicate efficacy in promoting neural, cardiac, and hepatic tissue stability under experimental stress conditions [5]. 

Anti‑Inflammatory & Antioxidant Modulation:

BPC‑157 Tablets have been shown to balance inflammatory signaling and counter oxidative stress in preclinical tests . 

Oral Bioavailability:

Unlike many peptides, BPC‑157 remains highly bioavailable when administered orally, with survival rates in simulated gastric conditions exceeding 90%. 

Safety Profile:

Preclinical safety data show low toxicity, absence of adverse immunogenic responses, and no overt hormonal interference in repeated animal administration [5]. 

Citations

1. PubChem, “BPC‑157 Compound Summary,” NCBI PubChem, CID 9941957. 
2. PubChem, BPC‑157 molecular details (formula, sequence). 
3. M. Staresinic et al., “Gastric pentadecapeptide BPC‑157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocyte growth,” J Orthop Res., 2003, 21(6):976–983. 
4. Chung‑Hsun Chang et al., “The promoting effect of pentadecapeptide BPC‑157 on tendon healing involves tendon outgrowth, cell survival, and cell migration,” J Appl Physiol., 2011, 110(3):774–780. 
5. PeptidesInstitute.org, “BPC‑157 Overview, Dosage, and Risks.”